Lataa...
Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers
The aim of this study is to prepare fluvastatin nanostructured lipid carriers (FLV-NLCs) in order to find an innovative way to alleviate FLV-associated disadvantages. The limitations include poor solubility and extensive first-pass metabolism, resulting in low (30%) bioavailability and short elimina...
Tallennettuna:
| Julkaisussa: | Int J Nanomedicine |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4577263/ https://ncbi.nlm.nih.gov/pubmed/26396513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S91556 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|